世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030


Monoclonal Antibodies In Veterinary Health Market Growth & Trends The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.42 billion by 2030, expanding at a ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年7月10日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
150 英語

本レポートは受注生産のため、5営業日程度ご納品のお時間をいただく場合がございます。


 

Summary

Monoclonal Antibodies In Veterinary Health Market Growth & Trends

The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.42 billion by 2030, expanding at a CAGR of 17.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company’s access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights

• Based on animal type, the dog segment held the dominant revenue share in 2022 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments

• Based on the application, the dermatology segment accounted for the largest market share of over 50% in 2022, owing to the increasing prevalence of canine atopic dermatitis

• The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2022, owing to the availability of advanced treatment facilities in veterinary hospitals

• The North America accounted for the largest market share of around 40% in 2022, owing to the presence of major market players in the region

ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. General Methodology
1.5. Research Scope & Assumptions
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Bottom-Up & Hybrid Model
1.7.3. CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Industry Analysis
3.3.1. Porter’s
3.3.2. PESTEL
3.4. Regulatory Framework
3.5. Product Pipeline Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, USD Million, 2022 & 2030
4.3. Dogs
4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Others
4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, USD Million, 2022 & 2030
5.3. Dermatology Market
5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Pain
5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End-User Estimates & Trend Analysis
6.1. Monoclonal Antibodies In Veterinary Health Market: End-User Movement Analysis, USD Million, 2022 & 2030
6.2. Veterinary Hospitals
6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Others
6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis
7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4. Japan
7.4.4.1. Key Country Dynamics
7.4.4.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East & Africa
7.6.1. SWOT Analysis
7.6.2. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participation Categorization
8.2. Key Company Profiles
8.2.1 Zoetis
8.2.2 Merck & Co, Inc.
8.2.3 Elanco
8.2.4 Boehringer Ingelheim GmbH
8.2.5 Indian Immunologicals Ltd
8.2.6 Virbac
8.2.6.1. Participant’s Overview
8.2.6.2. Product Benchmarking
8.2.6.3. Financial Performance
8.2.6.4. Strategy Mapping
8.3. List of Other Players (inclusive of companies with pipeline products)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

Grand View Research社のアニマルヘルス分野での最新刊レポート

本レポートと同じKEY WORD(dermatology)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る